Raffles Medical Group
Market Cap
S$1.8b
Last Updated
2019/10/23 12:34 UTC
Data Sources
Company Financials +
Executive Summary
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan.
Snowflake
Fundamentals
Excellent balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has Raffles Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
1.0%
BSL
-1.1%
SG Healthcare
1.1%
SG Market
1 Year Return
-3.8%
BSL
-11.1%
SG Healthcare
2.6%
SG Market
Return vs Industry: BSL exceeded the SG Healthcare industry which returned -11.1% over the past year.
Return vs Market: BSL underperformed the SG Market which returned 2.6% over the past year.
Shareholder returns
| BSL | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.0% | -1.1% | 1.1% |
| 30 Day | 1.0% | -1.3% | -0.3% |
| 90 Day | -1.0% | -5.7% | -5.9% |
| 1 Year | -1.4%-3.8% | -9.6%-11.1% | 6.7%2.6% |
| 3 Year | -28.7%-32.9% | -19.6%-24.5% | 15.5%3.2% |
| 5 Year | -14.4%-21.5% | -14.3%-23.4% | 12.0%-6.6% |
Price Volatility Vs. Market
How volatile is Raffles Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is Raffles Medical Group (SGX:BSL) A Risky Investment?3 weeks ago | Simply Wall St
Does Raffles Medical Group Ltd's (SGX:BSL) Past Performance Indicate A Weaker Future?1 month ago | Simply Wall St
Does Raffles Medical Group Ltd (SGX:BSL) Have A Good P/E Ratio?Valuation
Is Raffles Medical Group undervalued compared to its fair value and its price relative to the market?
10.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: BSL (SGD1.01) is trading below our estimate of fair value (SGD1.13)
Significantly Below Fair Value: BSL is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: BSL is poor value based on its PE Ratio (27.4x) compared to the Healthcare industry average (26.4x).
PE vs Market: BSL is poor value based on its PE Ratio (27.4x) compared to the SG market (13.4x).
Price to Earnings Growth Ratio
PEG Ratio: BSL is poor value based on its PEG Ratio (4.7x)
Price to Book Ratio
PB vs Industry: BSL is overvalued based on its PB Ratio (2.3x) compared to the SG Healthcare industry average (2.2x).
Next Steps
Future Growth
How is Raffles Medical Group forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
5.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BSL's forecast earnings growth (5.9% per year) is above the savings rate (2.3%).
Earnings vs Market: BSL's earnings (5.9% per year) are forecast to grow faster than the SG market (5.7% per year).
High Growth Earnings: BSL's earnings are forecast to grow, but not significantly.
Revenue vs Market: BSL's revenue (9.4% per year) is forecast to grow faster than the SG market (5.5% per year).
High Growth Revenue: BSL's revenue (9.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BSL's Return on Equity is forecast to be low in 3 years time (7.6%).
Next Steps
Past Performance
How has Raffles Medical Group performed over the past 5 years?
-2.2%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: BSL's earnings have declined by -2.2% per year over the past 5 years.
Accelerating Growth: BSL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BSL had negative earnings growth (-6.9%) over the past year, making it difficult to compare to the Healthcare industry average (-13.3%).
Return on Equity
High ROE: BSL's Return on Equity (7.9%) is considered low.
Return on Assets
ROA vs Industry: BSL's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: BSL's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Raffles Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: BSL's short term assets (SGD204.6M) exceeds its short term liabilities (SGD200.1M)
Long Term Liabilities: BSL's short term assets (204.6M) exceeds its long term liabilities (151.4M)
Debt to Equity History and Analysis
Debt Level: BSL's debt to equity ratio (15%) is considered satisfactory
Reducing Debt: BSL's debt to equity ratio has increased from 1% to 15% over the past 5 years.
Debt Coverage: BSL's debt is well covered by operating cash flow (71.1%).
Interest Coverage: BSL's interest payments on its debt are well covered by EBIT (362x coverage).
Balance Sheet
Inventory Level: BSL has a high level of physical assets or inventory.
Debt Coverage by Assets: BSL's debt is covered by short term assets (assets are 1.6x debt).
Next Steps
Dividend
What is Raffles Medical Group's current dividend yield, its reliability and sustainability?
2.48%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: BSL's dividend (2.48%) isn’t notable compared to the bottom 25% of dividend payers in the SG market (2.54%).
High Dividend: BSL's dividend (2.48%) is low compared to the top 25% of dividend payers in the SG market (5.69%).
Stable Dividend: BSL's dividend payments have been volatile in the past 10 years.
Growing Dividend: BSL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (67.8%), BSL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: BSL's dividends in 3 years are forecast to be covered by earnings (60.4% payout ratio).
Next Steps
Management
What is the CEO of Raffles Medical Group's salary, the management and board of directors tenure and is there insider trading?
3.7yrs
Average management tenure
CEO
Choon Yong Loo (70yo)
0yrs
Tenure
Dr. Loo Choon Yong co-founded Raffles Medical Group Ltd in 1976 and has been its Executive Chairman since 1997. Dr. Loo serves as Chief Executive Officer at Raffles Medical Group Ltd. In the area of public ...
Management Age and Tenure
3.7yrs
Average Tenure
70yo
Average Age
Experienced Management: BSL's management team is considered experienced (3.7 years average tenure).
Board Age and Tenure
7.1yrs
Average Tenure
67.5yo
Average Age
Experienced Board: BSL's board of directors are considered experienced (7.1 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Company |
| Shares | 1,122,500 |
| Max Price | S$1.12 |
| Entity | Company |
| Shares | 43,000 |
| Max Price | S$1.10 |
Ownership Breakdown
Management Team
Kenneth Wu
General Manager of Raffles Hospital
- Tenure: 0yrs
Walter Tan
Medical Director of Raffles Hospital
- Tenure: 0yrs
Soo Nan Tan (70yo)
Executive & Non-Independent Director
- Tenure: 19.3yrs
Alfred Loh
Senior Clinical Director of Raffles Medical
- Tenure: 0yrs
Choon Yong Loo (70yo)
Co-Founder
- Tenure: 0yrs
Kimmy Goh
Group Financial Controller & Company Secretary
- Tenure: 14.8yrs
Ann Goh (59yo)
Chief Financial Officer
- Tenure: 3.7yrs
Kah Teo
Chief ?Information ?Officer
- Tenure: 1.8yrs
Yih Yong
General Manager of Raffles Medical
- Tenure: 0yrs
Magdalene Lee
Senior Manager of Corporate Communications
- Tenure: 0yrs
Board Members
Pin Lim (82yo)
Non-Executive & Independent Director
- Tenure: 18.7yrs
Poh Tiong Koh (73yo)
Lead Independent Director
- Tenure: 5.8yrs
Eric Ang (65yo)
Non-Executive & Independent Director
- Tenure: 4.5yrs
Soo Nan Tan (70yo)
Executive & Non-Independent Director
- Tenure: 19.3yrs
Choon Yong Loo (70yo)
Co-Founder
- Tenure: 0yrs
Beng Geok Wee (71yo)
Non-Executive & Independent Director
- Tenure: 18.9yrs
Olivier Lim (54yo)
Non-Executive & Non-Independent Director
- Tenure: 5yrs
Teck Koon Kee (63yo)
Non-Executive & Independent Director
- Tenure: 7.8yrs
Raymond Lim (60yo)
Non-Executive & Independent Director
- Tenure: 6.5yrs
Sarah Lu (37yo)
Non-Executive & Non-Independent Director
- Tenure: 1.7yrs
Company Information
Raffles Medical Group Ltd's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Raffles Medical Group Ltd
- Ticker: BSL
- Exchange: SGX
- Founded: 1976
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: S$1.828b
- Shares outstanding: 1.83b
- Website: https://www.rafflesmedicalgroup.com/raffles-medical-group
Number of Employees
Location
- Raffles Medical Group Ltd
- 585 North Bridge Road
- Raffles Hospital, No. 11-00
- Singapore
- 188770
- Singapore
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| RAFL.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Apr 1997 |
| BSL | SGX (Singapore Exchange) | Yes | Ordinary Shares | SG | SGD | Apr 1997 |
Biography
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates in three segments: Healthcare services, H ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/23 12:34 |
| End of Day Share Price | 2019/10/23 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.